The best indicator for Martin Marietta Materials (MLM)
We backtested 20 indicators across daily, weekly and hourly charts on real Martin Marietta Materials (MLM) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
ADX / DMI
On the weekly chart, this is the strongest risk-adjusted edge we found for Martin Marietta Materials (MLM) over ~32.4 years — trailing buy-and-hold by 5.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | ADX / DMI ✓ | Weekly | 6.1% | 0.44 | -41.6% | 43.5% | 46 | -5.5% |
| 2 | CCI ✓ | Weekly | 7.1% | 0.43 | -52.4% | 80.6% | 31 | -4.5% |
| 3 | WaveTrend (8/6/4) ✓ | Weekly | 7.3% | 0.43 | -32.2% | 75.0% | 28 | -4.4% |
| 4 | EMA-10 Trend ✓ | Weekly | 7.0% | 0.42 | -64.7% | 44.8% | 145 | -4.7% |
| 5 | Donchian Breakout ✓ | Daily | 5.9% | 0.4 | -44.7% | 47.9% | 119 | -5.8% |
| 6 | MACD ✓ | Weekly | 6.2% | 0.4 | -66.7% | 44.4% | 63 | -5.4% |
| 7 | Donchian Breakout ✓ | Weekly | 5.7% | 0.4 | -58.3% | 52.0% | 25 | -5.9% |
| 8 | Williams %R ✓ | Weekly | 6.4% | 0.39 | -55.9% | 75.0% | 40 | -5.3% |
| 9 | Stochastic ✓ | Daily | 5.9% | 0.38 | -54.1% | 67.3% | 171 | -5.8% |
| 10 | SMA 50/200 Cross ✓ | Daily | 5.8% | 0.37 | -59.2% | 46.2% | 26 | -5.9% |
| 11 | Donchian Midline ✓ | Weekly | 5.8% | 0.37 | -73.4% | 44.3% | 88 | -5.8% |
| 12 | EMA 20/50 Cross ✓ | Daily | 5.7% | 0.36 | -69.6% | 38.8% | 80 | -6.0% |
| 13 | RSI Mean-Reversion ✓ | Daily | 4.3% | 0.36 | -48.2% | 76.6% | 47 | -7.4% |
| 14 | Bollinger Mean-Reversion ✓ | Weekly | 5.0% | 0.36 | -38.9% | 88.0% | 25 | -6.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Martin Marietta Materials (MLM), ADX / DMI on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.